©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Commentary on COVID-19-induced liver injury in various age and risk groups
Öner Özdemir, Hacer Efnan Melek Arsoy, Department of Pediatrics, Sakarya University, Medical Faculty, Sakarya 54100, Türkiye
Author contributions: Özdemir Ö and HE Melek Arsoy wrote the mini-review.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest to disclose.
Corresponding author: Öner Özdemir, MD, Professor, Department of Pediatrics, Sakarya University, Medical Faculty, Şirinevler Mahallesi Adnan Menderes Caddesi No. 193 Adapazarı, Sakarya 54100, Türkiye. ozdemir_oner@hotmail.com
Received: September 25, 2022
Peer-review started: September 25, 2022
First decision: November 5, 2022
Revised: November 15, 2022
Accepted: December 21, 2022
Article in press: December 21, 2022
Published online: January 25, 2023
Processing time: 114 Days and 15.4 Hours
Peer-review started: September 25, 2022
First decision: November 5, 2022
Revised: November 15, 2022
Accepted: December 21, 2022
Article in press: December 21, 2022
Published online: January 25, 2023
Processing time: 114 Days and 15.4 Hours
Core Tip
Core Tip: Coronavirus disease 2019 (COVID-19) can progress primarily with symptoms ranging from a mild upper respiratory tract infection to severe pneumonia, hepatic injury, and even death. There is currently increasing interest in COVID-19 interaction with liver tissue. We would like to discuss the details of liver injury/dysfunction in COVID-19 in the current literature.